13-DEOXYDOXORUBICIN
UNII 1S9VO1DQG5

Substance Identification & Data

This profile provides standardized clinical and technical data for 13-deoxydoxorubicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1S9VO1DQG5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 628290-43-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1S9VO1DQG5

CAS Registry Number

628290-43-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

13-DEOXYDOXORUBICIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H31NO10

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RGVRUQHYQSORBY-JIGXQNLBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C2494

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9829419

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(C(=O)c3c(C1=O)cccc3OC)c(O)c4c(c2O)C[C@](CCO)(O)C[C@@H]4O[C@@]5(O[C@@H](C)[C@H]([C@H](C5)N)O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 13-deoxydoxorubicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

13-DEOXYDOXORUBICIN

Systematic Nomenclature

5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYETHYL)-1-METHOXY-, (8R,10S)-

SYS